blog

How COVID-19 Is Changing Clinical Trial Patient Travel

By Mike Johnson on Thu, Jun 18, 2020 | 6 min read

 

We recently sat down with BBK’s Director of RSG Services Mike Johnson to discuss how clinical trial patient travel has been impacted by COVID-19 and how BBK's travel program RSG® Arrive has responded.

Topics: Patient Travel, RSG Arrive, COVID-19, Mike Johnson, RSG Services, Clinical Trial Patient Travel

COVID-19 Response Teaches Industry That Investing in Patient Partnership Is Key to All Research Endeavors

By Joan F. Bachenheimer, Founding Principal, CEO on Thu, May 28, 2020 | 6 min read

 

Rapid Adoption of Patient-centric Innovation Seen as Positive Outcome of COVID-19 Research Collaborations

While COVID-19 has severely affected many industries, scientific pursuit for a host of medical conditions is also threatened by sharply negative effects of the pandemic on clinical research for non-COVID-19-related pursuits. This is evidenced by an industry-reported 65 percent decline in new patient study enrollment in March 2020 relative to March 2019. The industry is adapting by borrowing from the zealous approach associated with COVID-19 research by deploying extraordinary collaboration and patient-centric services to achieve timelines for as many studies as possible.

Topics: Patient Centricity, Clinical Research, Clinical Trials, Clinical Trial Innovations, COVID-19, Joan F. Bachenheimer

Bonus Content: COVID-19 and Beyond Virtual Town Hall

By Elizabeth Gargill on Tue, May 26, 2020 | 2 min read

More of Your Questions Answered

In this special video clip, industry innovators Aaron Fleishman and Craig Lipset answer some of the overflow questions from our Virtual Town Hall on maintaining clinical trial momentum during COVID-19 and beyond.

This 20-minute segment features answers to your questions relating to:

  • Implementation of decentralized trials
  • Impact of COVID-19 on enrollment of healthy volunteers
  • Biggest concerns for clinicians around remote contact with patients
  • Advancing decentralized trials while not leaving behind people without access to reliable internet, electronic devices, or digital savvy
  • Validating new digital endpoints for decentralized trials
  • Impact of telemedicine and other decentralized trial approaches on  monitoring and source data verification (SDV)

 

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

Watch Now: COVID-19 and Beyond Virtual Town Hall

By Elizabeth Gargill on Tue, May 19, 2020 | 1 min read

Driven by audience questions, industry innovators Aaron Fleishman and Craig Lipset discuss maintaining clinical trial momentum during COVID-19 and beyond during our recent virtual town hall.

Watch now to gain insight into overcoming patient enrollment and engagement challenges while supporting study continuity. Learn how to minimize clinical trial disruption with solutions for all stages of study activity – planning, enrolling, and even restarting.

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

Study-Life Balance: Re-Envisioning the Patient Experience

By Jessica Kim on Mon, May 18, 2020 | 3 min read

 

Putting clinical trial participation
within the context of a patient’s entire life experience.

 

BBK Worldwide is marking the evolution of the patient experience with the introduction of a new construct called study-life balance. It leverages patient-centric solutions to help patients more easily integrate clinical trial participation into their daily lives. 

Topics: Patient Engagement, Patient Experience, Study-life Balance, International Clinical Trials

"COVID-19 and Beyond" Virtual Town Hall

By Elizabeth Gargill on Wed, May 6, 2020 | 1 min read

"COVID-19 and Beyond" Virtual Town Hall - May 14, 2020 @ 12:00 p.m. ET

Join industry innovators Craig Lipset and Aaron Fleishman for a virtual town hall to discuss maintaining clinical trial momentum during COVID-19 and beyond. Register now.

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

What and When to Submit to the IRB?

By Elizabeth Gargill on Wed, Apr 29, 2020 | 1 min read

Insights from Advarra on Managing Changes to Patient Enrollment & Engagement due to COVID-19

Get an IRB's perspective on managing clinical trial enrollment modifications due to COVID-19 by watching our interview with Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official, Advarra.

Topics: Patient Engagement, Pharma15 Live!, COVID-19, Clinical Trial Enrollment, Institutional Review Board, Rob Laurens, IRB

COVID-19: News You Can Use

By BBK Worldwide on Tue, Apr 28, 2020 | 1 min read

 

A Medication Delivery Success Story

In today's one-minute video update, Mike Johnson, Director of RSG® Services, discusses how BBK's Patient Visit Support Services helped patients in Brazil receive their study medication despite the COVID-19 lockdown.

Topics: Pharma15 Live!, COVID-19, Medication Transportation, RSG Patient Visit Support Services, News You Can Use

Maintaining Clinical Trial Momentum during COVID-19 and Beyond

By Elizabeth Gargill on Thu, Apr 23, 2020 | 1 min read

In our latest Pharma15 Live! COVID-19 special report, BBK's President Matt Kibby introduces a new framework for helping clinical trial sponsors maintain study momentum during COVID-19 and beyond.

The framework features strategies for minimizing disruption during four key stages of the study lifecycle.

Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, Coronavirus, Matt Kibby

Ramping Up Patient & Site Engagement during COVID-19

By Elizabeth Gargill on Tue, Apr 14, 2020 | 6 min read

 

Guidance to Help Respond to Immediate Challenges 

As the COVID-19 outbreak challenges clinical trial sponsors, we’ve identified efforts to support patient and site engagement -  helping to minimize clinical trial disruption and keep timelines intact. Some efforts respond to FDA guidance on conducting clinical trials during the COVID-19 pandemic while others respond to challenges introduced by travel restrictions, infection risks, enhanced site burden, and protocol deviations.

Topics: Patient Engagement, Site Engagement, RSG Arrive, COVID-19

 
Subscribe To Our Blog